Recent Onset Type 1 Diabetes clinical trials

Explore recruiting recent onset type 1 diabetes clinical trials.

Recruiting recent onset type 1 diabetes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recent Onset Type 1 Diabetes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents with Recent-Onset Type 1 Diabetes Mellitus

Czechia, Belgium, France, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the effect and safety of 400 mg twice a day oral ladarixin in patients with recent onset type 1 diabetes and a low residual β-cell function at baseline.

Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Grafalon®therapy within 12 weeks of Type 1 diabetes (T1D) diagnosis in children and young adults to prevent the loss of residual beta cell function: a randomised, double-blind, placebo-controlled dose finding study Acronym: GIRO T1D

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I/II Double-blind, randomized, placebo-controlled trial to preserve residual insulin secretion in children with recent onset Type 1 diabetes by giving oral Verapamil

Sweden

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Recent Onset Type 1 Diabetes trials by city

Recent Onset Type 1 Diabetes in Toronto Recent Onset Type 1 Diabetes in Vancouver Recent Onset Type 1 Diabetes in Montreal Recent Onset Type 1 Diabetes in Calgary Recent Onset Type 1 Diabetes in Edmonton Recent Onset Type 1 Diabetes in Ottawa Recent Onset Type 1 Diabetes in Winnipeg Recent Onset Type 1 Diabetes in Quebec City Recent Onset Type 1 Diabetes in Hamilton Recent Onset Type 1 Diabetes in Kitchener Recent Onset Type 1 Diabetes in London Recent Onset Type 1 Diabetes in Halifax Recent Onset Type 1 Diabetes in New York Recent Onset Type 1 Diabetes in Los Angeles Recent Onset Type 1 Diabetes in Chicago Recent Onset Type 1 Diabetes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease